Meet Our Advisory

Dr. Yelena Y. Janjigian

Chief of the Gastrointestinal Medical Oncology Service in the Division of Solid Tumor Oncology, Department of Medicine at Memorial Sloan Kettering Cancer Center in New York. Dr. Janjigian is an international expert in cancers of the esophagus and stomach.

Dr. Steven Barker

Pharmadrug’s lead advisor on R&D initiatives for DMT. Dr. Barker is actively involved in the research of psychedelics, with a primary focus on DMT since 1976. Dr Barker also is professor emeritus at Louisiana State University.

Dr. Jimo Borjigin

Associate Professor in the Department of Molecular and Integrative Physiology and the Department of Neurology at the University of Michigan. Dr. Borjigin received her PhD in Neuroscience from Johns Hopkins University and has been publishing foundational research on DMT since 2012.

Terry Booth

Global cannabis industry pioneer and founder of Aurora Cannabis (TSX- ACB). Mr.Booth brings Significant capital markets and M&A expertise, deep knowledge of the European cannabis markets and is a prominent investor in the psychedelics space.